Published February 1995
| Version v1
Journal article
The early development of hypothyroidism after 131I treatment for hyperthyroid Graves' disease
Creators
- 1. PUMC Hospital Beijing, Beijing (China). Dept. of Nuclear Medicine
Description
827 patients with Graves' hyperthyroidism following 131I treatment were followed up at 3 monthly intervals for 12∼36 months from 1985 to 1991. Physical examination and serum total T3, T4, TSH measurements were made at each visit. According to the authors data, 90% early hypothyroidism occurred within 2∼3 months after 131I treatment, thereby, careful follow-up study is very important during this period. T4 was much more sensitive than T3 in diagnosing early hypothyroidism, while the TSH level shows thyroid reservation function, and is less sensitive than T4 in diagnosing 131I induced hypothyroidism. The study confirmed the view that the early incidence of post 131I therapy hypothyroidism was strongly dose dependent
Additional details
Publishing Information
- Journal Title
- Chinese Journal of Nuclear Medicine
- Journal Volume
- 15
- Journal Issue
- 1
- Journal Page Range
- p. 26-28.
- ISSN
- 0253-9780
- CODEN
- CITCDE
INIS
- Country of Publication
- China
- Country of Input or Organization
- China
- INIS RN
- 27005543
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Resource subtype / Literary indicator
- Numerical Data
- Descriptors DEI
- DIAGNOSIS; EXPERIMENTAL DATA; HYPERTHYROIDISM; HYPOTHYROIDISM; IODINE 131; RADIATION DOSES; RADIOTHERAPY; SIDE EFFECTS; THYROID; THYROXINE; TRIIODOTHYRONINE; TSH
- Descriptors DEC
- AMINO ACIDS; BETA DECAY RADIOISOTOPES; BETA-MINUS DECAY RADIOISOTOPES; BODY; CARBOXYLIC ACIDS; DATA; DAYS LIVING RADIOISOTOPES; DISEASES; ENDOCRINE DISEASES; ENDOCRINE GLANDS; GLANDS; HORMONES; INFORMATION; INTERMEDIATE MASS NUCLEI; IODINE ISOTOPES; ISOTOPES; MEDICINE; NUCLEI; NUMERICAL DATA; ODD-EVEN NUCLEI; ORGANIC ACIDS; ORGANIC COMPOUNDS; ORGANIC HALOGEN COMPOUNDS; ORGANIC IODINE COMPOUNDS; ORGANS; PEPTIDE HORMONES; PITUITARY HORMONES; RADIOISOTOPES; THERAPY; THYROID HORMONES